By Rupen Mehta and Stephen Morehouse, PA Consulting
Most in the life sciences agree that artificial intelligence (AI) will reshape the sector from R&D through commercial. Although AI has only just left the starting gate, and most activity is in exploratory phases, some benefits are starting to emerge. And there are pockets of early adopters trailblazing new approaches and seeking a competitive edge to accelerate products to market, improve patient outcomes and care, and drive cost efficiencies.
White Paper |
By Florian A. Quarré,Ciox Health - Life Sciences
Digital innovations and their emerging technologies, such as artificial intelligence (AI), advanced analytics, and cloud-based computing, are transforming industries and markets across the world as they offer novel ways to boost R&D, increase product quality and safety, and ultimately improve customer satisfaction.
Trial Interactive turns 10 this year and we could not be more proud — from an early eTMF innovator to an end-to-end e-clinical platform, we’ve grown tremendously. Part of that growth was in realizing early that effective e-clinical innovation is powered by partnership and collaboration, which has been possible with 25+ years’ experience in the life sciences industry and 10 years of experience in e-clinical innovation.
Successful clinical trials require accurate demand forecasting, efficient distribution channels, and a secure supply chain strategy. Find out how Almac Clinical Services helped one sponsor implement an optimized clinical supply strategy that resulted in an uninterrupted clinical trial and reduced costs.
Clinical trials increasingly include patient populations that span the globe. To meet the needs of trial sponsors, Fisher Clinical Services continues to expand its global network by adding new facilities in emerging markets and enhancing capacity and services at existing sites.